PH15619A - 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate - Google Patents

1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Info

Publication number
PH15619A
PH15619A PH21415A PH21415A PH15619A PH 15619 A PH15619 A PH 15619A PH 21415 A PH21415 A PH 21415A PH 21415 A PH21415 A PH 21415A PH 15619 A PH15619 A PH 15619A
Authority
PH
Philippines
Prior art keywords
tetrahydrofuroyl
quinazolinyl
dimethoxy
amino
piperazine hydrochloride
Prior art date
Application number
PH21415A
Inventor
Robert Roteman
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PH15619A publication Critical patent/PH15619A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PH21415A 1977-08-04 1978-07-24 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate PH15619A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82167577A 1977-08-04 1977-08-04

Publications (1)

Publication Number Publication Date
PH15619A true PH15619A (en) 1983-02-28

Family

ID=25234014

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21415A PH15619A (en) 1977-08-04 1978-07-24 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate

Country Status (4)

Country Link
JP (1) JPS63211229A (en)
MX (1) MX5483E (en)
PH (1) PH15619A (en)
SE (2) SE437157B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride

Also Published As

Publication number Publication date
SE437157B (en) 1985-02-11
MX5483E (en) 1983-08-23
SE455373B (en) 1988-07-11
SE8400042D0 (en) 1984-01-04
SE7808316L (en) 1979-02-05
JPS63211229A (en) 1988-09-02
JPH0259127B2 (en) 1990-12-11
SE8400042L (en) 1984-01-04

Similar Documents

Publication Publication Date Title
AU517636B2 (en) 1 (4-amino-6, 7-dimethoxy-2-quinazolinyl) 4 (2 tetrahydrofuroyl) piperazine hydrochloride dihydrate
HK42781A (en) 4-amino-6,7-dimethoxy-2-(4-(heterocyclocarbonyl)piperozin-1-yl)quinazolines
FI832658A0 (en) 2-SUBSTITUTES 4-AMINO-6,7-DIMETOXYQUINOLINER
FI801229A (en) 4-AMINO-3-CARBOXY-ELLER CYANO-1,2-DIHYDRO-2-OXO-1,8-NAPHTHYRIDE DERIVATIVES
IT7819724A0 (en) CEMENTED CARBIDE.
DK210483D0 (en) PYROGALLOOL DERIVATIVES, THEIR USE AND THE PROCEDURES FOR PRODUCING THEREOF
PH14659A (en) 1-(3-or 4-substituted piperidino)phthalazones
IL51481A (en) Crystalline -form of-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxy quinazoline hydrochloride and its preparation
AT350133B (en) POCKET AUXILIARY AID
NZ187066A (en) 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones)
NL7808319A (en) 2-PYRIDYL AND 2-PYRIMIDYL DERIVATIVES.
PH15619A (en) 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
NL7807380A (en) ROLL-DOWN TABLE.
CY1122A (en) 4-amino-6,7-dimethoxy-2-(4-(hetero-cyclo-carbonyl)piperazin-1-yl)quinazolines
DK158352C (en) PROCEDURE FOR PREPARING 6,7-DIMETHOXY-4-AMINO-2- (4- (2-FUROYL) -1-PIPERAZINYL) CHINAZOLINE HYDROCHLORIDE
PH22196A (en) Novel 4-(cyclic imido-substituted)-6,7-dimethoxy quinazoline derivatives
PH20015A (en) N-(1-(4-amino-6,7-dialkoxy-2-quinazolinyl)-4-piperidyl)-oxazolidine-2,4-diones
YU175483A (en) Process for obtining crystlline 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride
YU171577A (en) Process for obtaining 2-(4-(2-furoyl)piperazine-1-yl)4-amino-6,7-dimethoxy-quinazoline
YU41908B (en) Process for proucing the crystalline form of 1-(4-amino-6,7-dimethoxy-2-quinazoliyl)-4-(2-furoyl)-piperazine hydrochloride
BG42903A1 (en) Method for preparing crystal alpha form of 1- (4- amino- 6, 7- dimetoxy- 2- quanazolyl)- 4- (2- furoyl)- piperazine hydrochloride
FI855121A (en) KOPPLINGSANORDNING FOER KOMMUNIKATIONSANLAEGGNINGAR, SAERSKILT TELEFONANLAEGGNINGAR, MED TILL FOERMEDLINGSSTAELLEN VIA LEDNINGSKNIPPEN ANSLUTNA UNDERFOERMEDLINGSSTAELLEN.
BG47571A1 (en) Method for preparing of crystal alpha- form of 1- (4- amino- 6, 7- dimetoxy- 2- quinazolinyl)- 4- (2- furoyl)- piperazine hydrochloride
ES226152Y (en) NEW CERAMIC BLOCK.
FI763614A (en) MELLANPRODUKT FOER FRAMSTAELLNING AV 6,7-DIMETOXI-4-AMINO-2- (4- (2-FUROYL) -1-PIPERAZINYL) QUINATZOLIN MED BLODTRYCKSSAENKANDE NETKAN

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 14